caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1871565887

Dina PrusMD

EndocrinologyMaplewood, NJI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Dina Prus's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 10 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Frederick Gangemi
Physical Medicine and Rehabilitation · Belleville, NJ
84159
NPI 137658261977188
Brian Feehan
Cardiology · Cedar Knolls, NJ
54142
Peter Pasley
Internal Medicine · New York, NY
3982
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
3786
NPI 10938193362245
Cooperman Barnabas Medical Center Inc
Medicare Diabetes Preventive Program · Livingston, NJ
2270
Mark Lichtenberg
Dermatology · Springfield, NJ
2047
John Kelly
Internal Medicine · Bloomfield, NJ
16241
NEWARK BETH ISRAEL MEDICAL CENTER INC1430
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
176
Unique beneficiaries
—
Total services
232
Distinct HCPCS
3
Medicare payment
$18K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 290 Endocrinology providers in NJ — bottom quintile (cohort median 1,480).
PRESCRIBING · PART D · 2024
Total Rx claims
4,039
Beneficiaries
—
Total drug cost
$1.5M
Distinct drugs
43
Brand share
49.4%
Top prescribed drugs
Levothyroxine Sodium431 claims
Metformin Hcl391 claims
Atorvastatin Calcium281 claims
Semaglutide164 claims
Insulin Glargine,hum.Rec.Anlog159 claims
QUALITY · MIPS · 2024
Final MIPS score
85.2
Quality
71.6
Cost
76.7
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.43%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$35
Payment records
1
By payment type
Food and Beverage$35